The interdepartmental CURE: Digestive Diseases Research Core Center (CURE: DDRCC), funded continuously since 1989, is composed of 68 members and 26 associate members comprising a multidisciplinary group of physicians and basic scientists with strong independent peer-reviewed grant-supported programs in basic, translational and clinical research of the digestive system. Annual direct digestive diseases-related grant support for the research base is $16,858,584 including $6,089,729 from NIDDK. The current programs of this Research Base can be broadly divided in three major and interrelated complementary areas: A) Molecular and integrative mechanisms of gastrointestinal and pancreatic physiology and inflammation; B) Bidirectional brain-gut interactions and functional disorders of the digestive system; C) Mechanism of action of neuro-hormonal Gl signals: receptor regulation, signal transduction and control of normal and abnormal cell proliferation. The Biomedical Research Cores outlined in this proposal provide ready access to technologies and to clinical and biological materials that are essential to the programs of center members. These Cores offer access to modern cellular imaging to study signaling proteins and their functions, facilitate intestinal stem cell biology, provide animal models and techniques for studying integrative physiology and pathophysiology, molecular vectors to express a wide variety of proteins and access to a broad range of techniques and patients for clinical studies. The Administrative Core gives a wide range of administrative support for members and for center activities, including a comprehensive and multidisciplinary enrichment program. The Pilot and Feasibility Study program has provided a very successful mechanism for promoting the development of new programs and ideas in digestive diseases related research, primarily by young investigators. The CURE: DDRCC, enhanced by substantial direct institutional support, provides a forum, strategic vision and programmatic integration in which faculty members can advance the understanding of fundamental mechanisms relating to the function, disorders and diseases of the digestive system by making their combined efforts much greater than the sum of the parts.

Public Health Relevance

The CURE DRRCC comprises a multidisciplinary research base dedicated to advancing our understanding of the biology, functional disorders and diseases of the digestive system. Scientific core facilities, Pilot and Feasibility Study awards an enrichment programs provide a platform of novel technologies, services and interactions to promote the collaborative research efforts of the CURE: DDRCC membership.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK041301-26
Application #
8769369
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (M2))
Program Officer
Podskalny, Judith M,
Project Start
1996-12-01
Project End
2019-11-30
Budget Start
2015-02-02
Budget End
2015-11-30
Support Year
26
Fiscal Year
2015
Total Cost
$936,455
Indirect Cost
$235,208
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Salehi, Sahar; Sosa, Rebecca A; Jin, Yi-Ping et al. (2018) Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection. Am J Transplant 18:1096-1109
Biczo, Gyorgy; Vegh, Eszter T; Shalbueva, Natalia et al. (2018) Mitochondrial Dysfunction, Through Impaired Autophagy, Leads to Endoplasmic Reticulum Stress, Deregulated Lipid Metabolism, and Pancreatitis in Animal Models. Gastroenterology 154:689-703
Fulcher, Jennifer A; Shoptaw, Steven; Makgoeng, Solomon B et al. (2018) Brief Report: Recent Methamphetamine Use Is Associated With Increased Rectal Mucosal Inflammatory Cytokines, Regardless of HIV-1 Serostatus. J Acquir Immune Defic Syndr 78:119-123
Jin, Yi-Ping; Valenzuela, Nicole M; Zhang, Xiaohai et al. (2018) HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection. J Immunol 200:2372-2390
Gupta, Arpana; Mayer, Emeran A; Labus, Jennifer S et al. (2018) Sex Commonalities and Differences in Obesity-Related Alterations in Intrinsic Brain Activity and Connectivity. Obesity (Silver Spring) 26:340-350
Wang, Bo; Rong, Xin; Palladino, Elisa N D et al. (2018) Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis. Cell Stem Cell 22:206-220.e4
Chen, Wenling; Ennes, Helena S; McRoberts, James A et al. (2018) Mechanisms of ?-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord. Neuropharmacology 128:255-268
Strege, Peter R; Mazzone, Amelia; Bernard, Cheryl E et al. (2018) Irritable bowel syndrome patients have SCN5A channelopathies that lead to decreased NaV1.5 current and mechanosensitivity. Am J Physiol Gastrointest Liver Physiol 314:G494-G503
Mazzoni, M; Karunaratne, T B; Sirri, F et al. (2018) Enteroendocrine profile of ?-transducin and ?-gustducin immunoreactive cells in the chicken (Gallus domesticus) gastrointestinal tract. Poult Sci 97:4063-4072
Hilfenhaus, Georg; Nguyen, Dai Phuong; Freshman, Jonathan et al. (2018) Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers. J Cell Biol 217:2813-2830

Showing the most recent 10 out of 1097 publications